
Astrana Health Inc.: updates and filings
Price
$29.65
November 18, 2026Market cap $1.6B
What Ploutos Investor adds for Astrana Health
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from FY2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 30, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 23, 2026Regulation FD disclosureForm8-K
- Sep 23, 2026Material cybersecurity incidentForm8-K
- Sep 15, 2026Regulation FD disclosureForm8-K
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operations, Regulation FD disclosureForm8-K
- Jul 31, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 13, 2026Regulation FD disclosureForm8-K
- Jul 1, 2026Officer or director changeForm8-K
- Jun 11, 2026Shares registered for employeesFormS-8
- Jun 10, 2026Officer or director change, shareholder voteForm8-K
- May 12, 2026Officer or director changeForm8-K
- May 12, 2026Regulation FD disclosureForm8-K
- May 8, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 17, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 17, 2026Additional annual meeting materialFormDEFA14A
- Apr 17, 2026Annual meeting proxy statementFormDEF 14A
- Mar 31, 2026Shelf registration for future offeringsFormS-3ASR
- Mar 31, 2026Shelf registration for future offeringsFormS-3ASR
- Mar 30, 2026Other material eventsForm8-K
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 12, 2026Annual reportfor the period to Dec 31, 2025Form10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 30, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 23, 2026 | 8-K | Regulation FD disclosure | Document |
| Sep 23, 2026 | 8-K | Material cybersecurity incident | Document |
| Sep 15, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jul 31, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Jul 1, 2026 | 8-K | Officer or director change | Document |
| Jun 11, 2026 | S-8 | Shares registered for employees | Document |
| Jun 10, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| May 12, 2026 | 8-K | Officer or director change | Document |
| May 12, 2026 | 8-K | Regulation FD disclosure | Document |
| May 8, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 17, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 17, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 17, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 31, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Mar 31, 2026 | S-3ASR | Shelf registration for future offerings | Document |
| Mar 30, 2026 | 8-K | Other material events | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 12, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 19, 1999.
The full analysis
What do Astrana Health's filings show?
The filings are where every one of Astrana Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.